medline.ch Gastroenterologie Oesophagus Neoplasie

	The complication sum score: A Delphi-based approach to summarize treatment related complications for esophageal cancer. Clin Transl Radiat Oncol Frederiks ML, Berbée M, Wijnhoven BPL, Schuit E, van Rossum PSN, Meijer GJ, Mook S, Nuyttens JJ, Rütten H, den Hartogh MD, van Etten B, Langendijk JA, van Laarhoven HWM, Muijs CT, MODELS consortium. PMID: 42005718 [PubMed - as supplied by publisher]
	Phase II randomized trial of 41.4Â Gy vs. 50.4Â Gy in neoadjuvant chemoradiotherapy for resectable esophageal cancer. Clin Transl Radiat Oncol Esmati E, Nazari R, Aqamolaei A, Maddah Safaei A, Miri R, Shirkhoda M, Jalaeefar A, Salarvand S, Aghili M, Farhan F, Mousavi Darzikolaee N, Kolahdouzan K, Abyaneh R, Ghalehtaki R. PMID: 42005715 [PubMed - as supplied by publisher]
	Advancing Particle Therapy to Improve Cancer Care: Report on "2nd World Forum on Particle Therapy". Int J Part Ther Hug E, Burnet NG, Simone CB, Calvo FA, De Ruysscher DJ, Flanz J, Fossati P, Guha C, Hoppe BS, Lu HM, Mahajan A, Shih HA, Frank SJ, for and on behalf of the 2nd World Forum collaborators. PMID: 42005556 [PubMed - as supplied by publisher]
	Safety of [(68)Ga]Ga-FAPI-46 PET/CT including hemodynamic measurements and patient-reported outcomes in cancer patients. Clin Physiol Funct Imaging Bentestuen M, Sylvest C, Jensen SB, Soro LR, Knudsen A, Ladekarl M, Thorlacius-Ussing O, Fendler WP, Zacho HD. PMID: 42002985 [PubMed - indexed for MEDLINE]
	Long non-coding RNAs as regulators of immune signaling pathways in esophageal cancer. Biochem Pharmacol Uttam V, Rana MK, Sethi G, Jain A. PMID: 42002235 [PubMed - as supplied by publisher]
	Survival advantage of conversion surgery following induction therapy in cT4 esophageal cancer: A systematic review and meta-analysis. Eur J Surg Oncol Jiang KY, Zhang LD, Zhong AL, Hu WL, Wang JJ, Zhang JJ, Mao YY, Deng ZQ, Tian D. PMID: 42001566 [PubMed - as supplied by publisher]
	Incidence and risk factors of short-term cardiovascular events in esophageal cancer patients undergoing radiotherapy. Dis Esophagus Lee WC, Yang CC, Chen YC, Ho CH, Shih JY, Chen ZC, Chang WT. PMID: 42001476 [PubMed - indexed for MEDLINE]
	Relationship between immune-related adverse events and long-term survival in patients treated with immune checkpoint inhibitors for unresectable advanced or recurrent esophageal cancer. Dis Esophagus Matsui K, Miyawaki Y, Suzuki Y, Furube T, Yoshizawa M, Toriumi T, Ebara G, Sato H, Sakuramoto S. PMID: 42001475 [PubMed - indexed for MEDLINE]
	Effects of intranasal long-acting insulin pretreatment on postoperative delirium and the NLRP3/caspase-1/IL-1Î² pathway in older patients with esophageal cancer. Inflamm Regen Zhang Y, Wu W, Zhong Z, Liu Y, Gong G, Huang Q. PMID: 41998765 [PubMed - as supplied by publisher]
	Testing Claudin 18.2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma: Current Status and Nearâ€‘Future Outlook. Cesk Patol Dundr P, Mat. PMID: 41996257 [PubMed - indexed for MEDLINE]
	Japanese prospective registry study of particle therapy for esophageal cancer including comparison with clinical trials in Japan. Esophagus Ono T, Ishikawa H, Tokumaru S, Soejima T, Isozaki T, Kimoto T, Hojo H, Hiroshima Y, Takakusagi Y, Maruo K, Umehara K, Hashimoto T, Kamei T, Muto M, Sakurai H. PMID: 41989506 [PubMed - as supplied by publisher]
	The geriatric nutritional risk index predicts pathological complete response and anastomotic leakage in esophageal cancer patients undergoing neoadjuvant therapy. J Thorac Dis Niu J, Huang J, Zhang M, Yang B, Lu T. PMID: 41988286 [PubMed]
	Prognostic impact of treatment modalities and examined lymph nodes count on survival in T3-4 esophageal cancer: a retrospective cohort and predictive modeling study from the Surveillance, Epidemiology, and End Results database. J Thorac Dis Wu Y, Shi P, Yang P, Yang T, Zhang J, Li S, Feng L, Zhu B, Wu Z. PMID: 41988283 [PubMed]
	The central regulator HIF-1Î± in digestive system pathologies: inflammation and cancer. Front Immunol Gou G, Wen M, Li G, Shu F, Wang F, Liu Y, Xie R, Xu J. PMID: 41988193 [PubMed - indexed for MEDLINE]
	Retrospective analysis of postoperative adjuvant therapy and survival in T4 esophageal squamous cell carcinoma: a dual-cohort study using SEER and Chinese multicenter data. Front Med (Lausanne) Xu ZC, Li JC. PMID: 41987784 [PubMed]
	Cost-effectiveness of pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma. Hum Vaccin Immunother Yu K, Xu Q. PMID: 41987583 [PubMed - indexed for MEDLINE]
	[Esophagobronchial fistula]. Rev Med Liege Rouffignon P, Herman L, Fievet F. PMID: 41987539 [PubMed - indexed for MEDLINE]
	Esophageal cancer: from pathogenesis to precision therapies. Signal Transduct Target Ther Zhang S, Shen Y, Zhu L, Lai Y, Zhu L, Xiao X, Li J, Tan W, Lin D, Wu C. PMID: 41986343 [PubMed - indexed for MEDLINE]
	Lifestyle and Environmental Risk Factors for Esophageal Squamous Cell Carcinoma: Evidence From the Johannesburg Cancer Study. JCO Glob Oncol Chen WC, Bradshaw D, Ramaliba T, Babb de Villiers C, Newton R, Waterboer T, Mathew CG, Muchengeti M, Sitas F. PMID: 41985117 [PubMed - indexed for MEDLINE]
	Surgical approaches to esophageal cancer gastrointestinal reconstruction: a systematic review of jejunum, colon, and ileocolonic interposition with comparative outcome analysis. World J Surg Oncol Liu X, Dai J, Yin M, Zhang R, Song Y. PMID: 41981663 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 38642

Seite 1 von 1933

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung